Sleep Disorders have received much attention in recent years, as they are related to the risk and pathogenesis of neurodegenerative diseases. Notably, REM Sleep Behaviour Disorder (RBD) is considered an early symptom of α-synucleinopathies, with a conversion rate to Parkinson’s Disease (PD) up to 90%.